PeptidePedia The community reference

Contributions of Hedgerow_Hal

User contributions·78 logged edits·page 1 of 1

Contributions by Hedgerow_Hal, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 22,940 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Asymchem Laboratories 10,895 +485 m expand §Independent testing record
  2. 17:39, 14 Jul 2026 (diff | hist) Satiety signalling 5,593 ±0 fix hyphenation per PP:MOS
  3. 10:57, 4 Jul 2026 (diff | hist) Talk:Cold chain 1,644 +130 /* Lead is four paragraphs and the fourth is an argument */ reply
  4. 17:34, 6 Jun 2026 (diff | hist) Sharps disposal 14,443 +1,334 state that reconstituted material should not be frozen, with the source
  5. 08:32, 3 Jun 2026 (diff | hist) Talk:Sharps disposal 822 +106 /* Register: §Improvised containers reads as instruction */ reply
  6. 09:47, 2 Jun 2026 (diff | hist) Talk:Sharps disposal 400 +363 /* Register: §Improvised containers reads as instruction */ new section
  7. 14:22, 8 May 2026 (diff | hist) Talk:Temperature excursion 1,159 +323 /* Assessment sequence reads as a procedure */ reply
  8. 13:54, 19 Apr 2026 (diff | hist) GLP-1 receptor 7,570 ±0 give the fasting and postprandial concentrations with the assay named
  9. 04:28, 6 Apr 2026 (diff | hist) Peptide stability table 6,886 ±0 add the source for each stability figure in the table
  10. 09:44, 3 Apr 2026 (diff | hist) Talk:Glucagon-like peptide-1 1,381 +214 /* Readability of the signalling section */ reply
  11. 03:56, 19 Mar 2026 (diff | hist) Insulin syringe unit conversion 6,290 ±0 the calculator rounded before dividing; corrected
  12. 02:00, 19 Mar 2026 (diff | hist) Syringe dead space 20,859 +519 m correct the needle gauge given for subcutaneous administration
  13. 16:05, 15 Mar 2026 (diff | hist) Talk:Enteroendocrine L cell 748 +159 /* Microbiome mention feels speculative */ reply
  14. 14:12, 25 Feb 2026 (diff | hist) Talk:Dual incretin agonist 748 +161 /* Numbered list in the middle section */ reply
  15. 22:58, 18 Feb 2026 (diff | hist) Global access disparity 4,391 ±0 ce
  16. 09:30, 15 Feb 2026 (diff | hist) Talk:Incretin effect 885 +260 /* Type 1 diabetes section may be original research */ reply
  17. 14:02, 11 Feb 2026 (diff | hist) Talk:Reconstitution calculator 1,022 +223 /* Requested move: → Peptide reconstitution calculator */ reply
  18. 13:25, 9 Feb 2026 (diff | hist) Talk:Beyond-use date 1,455 +267 /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply
  19. 06:04, 1 Feb 2026 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 split §Physiology from §Pharmacological exploitation
  20. 21:38, 4 Jan 2026 (diff | hist) Custom peptide synthesis 4,773 ±0 m add the shelf temperature and the primary drying step to the cycle description
  21. 04:53, 1 Dec 2025 (diff | hist) Vial filling and stoppering 4,833 ±0 clarify that the cake appearance is an indicator, not a specification
  22. 10:55, 13 Nov 2025 (diff | hist) Talk:Vial 1,307 +108 /* The unmarked-vial paragraph is close to describing evasion */ reply
  23. 23:18, 1 Oct 2025 (diff | hist) Loss on drying 4,874 ±0 give the injection volume, without which the loading cannot be judged
  24. 00:52, 24 Sep 2025 (diff | hist) Hubei Jianxiang Bioscience 9,693 +819 m label the reception tally as weak, self-selected evidence at this point of use
  25. 13:02, 4 Sep 2025 (diff | hist) Talk:GenScript Peptides 611 +207 /* Notability, and what a long registry record does not establish */ reply
  26. 14:15, 2 Sep 2025 (diff | hist) Talk:Wuhan Wansheng Biotechnology 748 +292 /* What does the largest report set on the wiki support? */ reply
  27. 12:48, 13 Aug 2025 (diff | hist) Talk:Shenzhen Hybio Pharmaceutical 611 +297 /* Notability, and what a long registry record does not establish */ reply
  28. 03:52, 20 Jul 2025 (diff | hist) Lixisenatide 4,057 ±0 give the isoelectric point with the method it was determined by
  29. 18:07, 2 Jul 2025 (diff | hist) Baseline laboratory panel 4,222 ±0 m expand §Why consistency matters more than completeness
  30. 09:55, 16 Jun 2025 (diff | hist) Zhuhai Kerui Biotechnology 4,194 +1,443 add the registered legal name exactly as it appears in the registry record
  31. 09:35, 11 Jun 2025 (diff | hist) Talk:Zhuhai Kerui Biotechnology 822 +230 /* Method disclosure: are we writing an endorsement? */ reply
  32. 14:02, 10 Jun 2025 (diff | hist) Talk:SinoPep 611 +181 /* Notability, and whether a documentary distinction is a notable one */ reply
  33. 12:03, 13 May 2025 (diff | hist) Satiety signalling 4,470 +29 rm the causal claim about appetite — the cited work is associative
  34. 04:13, 10 Apr 2025 (diff | hist) Peptide supply chain 6,954 +894 give the closure integrity test by name
  35. 15:07, 24 Mar 2025 (diff | hist) Prior authorisation 3,094 +844 m rm the advice on how to obtain coverage
  36. 13:05, 19 Mar 2025 (diff | hist) Talk:Insulin syringe unit conversion 748 +209 /* Rounding warning: is it original research? */ reply
  37. 10:26, 14 Feb 2025 (diff | hist) Talk:Chinese Peptide Company 1,033 +60 /* Requested move: → Chinese Peptide Company Co., Ltd. */ reply
  38. 13:25, 10 Feb 2025 (diff | hist) Injection site rotation 3,897 +342 m state the syringe graduation the unit figure assumes
  39. 04:29, 8 Feb 2025 (diff | hist) CagriSema 3,776 +787 add the excipient list from the labelling
  40. 09:52, 17 Jan 2025 (diff | hist) Talk:Bachem Holding (Suzhou) 822 +214 /* The name coincidence: how much should the article say? */ reply
  41. 17:19, 7 Jan 2025 (diff | hist) STEP trial programme 4,064 ±0 m expand §Design features that shape the figures
  42. 13:09, 22 Nov 2024 (diff | hist) Melanotan II 1,177 ±0 split overlong sentence
  43. 10:03, 22 Nov 2024 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 822 +211 /* Notability and the registered business scope */ reply
  44. 14:26, 18 Nov 2024 (diff | hist) Talk:Tianjin Finder Chemical 611 +290 /* Manufacturer or distributor? */ reply
  45. 09:18, 12 Sep 2024 (diff | hist) Talk:Qingdao Sigma Chemical 822 +111 /* Attributed founding year versus registry record */ reply
  46. 14:03, 11 Sep 2024 (diff | hist) Talk:Research use only 611 +245 /* Should the warning box be a banner instead? */ reply
  47. 15:27, 4 Sep 2024 (diff | hist) Talk:Glucagon-like peptide-1 1,033 +197 /* Residue numbering — (7–36) versus (1–30) */ reply
  48. 13:47, 12 Aug 2024 (diff | hist) Talk:WuXi TIDES 611 +300 /* Notability, and the name problem */ reply
  49. 13:31, 12 Aug 2024 (diff | hist) Talk:Cold chain 611 +273 /* Storage definitions: table or prose? */ reply
  50. 15:28, 26 Jul 2024 (diff | hist) WuXi TIDES 1,776 ±0 m expand §Reception
  51. 10:23, 5 Jul 2024 (diff | hist) Talk:AmbioPharm 1,096 +156 /* Standing note: what this article may not contain */ reply
  52. 10:23, 5 Jul 2024 (diff | hist) Talk:Asymchem Laboratories 1,096 +156 /* Standing note: what this article may not contain */ reply
  53. 10:23, 5 Jul 2024 (diff | hist) Talk:Bachem Holding (Suzhou) 1,096 +156 /* Standing note: what this article may not contain */ reply
  54. 10:23, 5 Jul 2024 (diff | hist) Talk:ChinaPeptides 1,096 +156 /* Standing note: what this article may not contain */ reply
  55. 10:23, 5 Jul 2024 (diff | hist) Talk:Chinese Peptide Company 1,096 +156 /* Standing note: what this article may not contain */ reply
  56. 10:23, 5 Jul 2024 (diff | hist) Talk:Flourishglobal Peptide Biotech 1,096 +156 /* Standing note: what this article may not contain */ reply
  57. 10:23, 5 Jul 2024 (diff | hist) Talk:GenScript Peptides 1,096 +156 /* Standing note: what this article may not contain */ reply
  58. 10:23, 5 Jul 2024 (diff | hist) Talk:GL Biochem (Shanghai) 1,096 +156 /* Standing note: what this article may not contain */ reply
  59. 10:23, 5 Jul 2024 (diff | hist) Talk:Guangzhou JEEP Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
  60. 10:23, 5 Jul 2024 (diff | hist) Talk:Hubei Jianxiang Bioscience 1,096 +156 /* Standing note: what this article may not contain */ reply
  61. 10:23, 5 Jul 2024 (diff | hist) Talk:Hunan Aslsen Technology 1,096 +156 /* Standing note: what this article may not contain */ reply
  62. 10:23, 5 Jul 2024 (diff | hist) Talk:Nantong Guangyuan Chemical 1,096 +156 /* Standing note: what this article may not contain */ reply
  63. 10:23, 5 Jul 2024 (diff | hist) Talk:PolyPeptide Group (Hangzhou) 1,096 +156 /* Standing note: what this article may not contain */ reply
  64. 10:23, 5 Jul 2024 (diff | hist) Talk:Qingdao Saber Technology Pharmaceutical 1,096 +156 /* Standing note: what this article may not contain */ reply
  65. 10:23, 5 Jul 2024 (diff | hist) Talk:Qingdao Sigma Chemical 1,096 +156 /* Standing note: what this article may not contain */ reply
  66. 10:23, 5 Jul 2024 (diff | hist) Talk:Sangon Biotech 1,096 +156 /* Standing note: what this article may not contain */ reply
  67. 10:23, 5 Jul 2024 (diff | hist) Talk:Shanghai ERP Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
  68. 10:23, 5 Jul 2024 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 1,096 +156 /* Standing note: what this article may not contain */ reply
  69. 10:23, 5 Jul 2024 (diff | hist) Talk:Shanghai Wibson Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
  70. 10:23, 5 Jul 2024 (diff | hist) Talk:Shenzhen Hybio Pharmaceutical 1,096 +156 /* Standing note: what this article may not contain */ reply
  71. 10:23, 5 Jul 2024 (diff | hist) Talk:Sigma-Aldrich (Shanghai) Trading 1,096 +156 /* Standing note: what this article may not contain */ reply
  72. 10:23, 5 Jul 2024 (diff | hist) Talk:SinoPep 1,096 +156 /* Standing note: what this article may not contain */ reply
  73. 10:23, 5 Jul 2024 (diff | hist) Talk:Thermo Fisher Scientific (China) 1,096 +156 /* Standing note: what this article may not contain */ reply
  74. 10:23, 5 Jul 2024 (diff | hist) Talk:Tianjin Finder Chemical 1,096 +156 /* Standing note: what this article may not contain */ reply
  75. 10:23, 5 Jul 2024 (diff | hist) Talk:Wuhan Wansheng Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
  76. 10:23, 5 Jul 2024 (diff | hist) Talk:WuXi TIDES 1,096 +156 /* Standing note: what this article may not contain */ reply
  77. 10:23, 5 Jul 2024 (diff | hist) Talk:Xi'an Mokemei Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
  78. 10:23, 5 Jul 2024 (diff | hist) Talk:Zhuhai Kerui Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply